532 related articles for article (PubMed ID: 26439105)
61. Comparison of nimodipine delivery routes in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits.
Onal MB; Civelek E; Kircelli A; Solmaz I; Ugurel S; Narin F; Isikay I; Bilginer B; Yakupoglu H
Acta Neurochir Suppl; 2011; 110(Pt 2):23-8. PubMed ID: 21125440
[TBL] [Abstract][Full Text] [Related]
62. [Effectiveness and safety of nimodipine in preventing cerebral vasospasm after subarachnoid hemorrhage in children].
Song Y; Qian SY; Li Y; Liu J; Li Z; Jia XL; Gao HM; Zeng JS
Zhonghua Er Ke Za Zhi; 2019 May; 57(5):338-343. PubMed ID: 31060125
[No Abstract] [Full Text] [Related]
63. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
Heffren J; McIntosh AM; Reiter PD
Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
[TBL] [Abstract][Full Text] [Related]
64. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.
Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Zhang Y; Xu B; Zhao K; Wang R; Mao Y; Xu B; Zhang X;
Neurol Med Chir (Tokyo); 2011; 51(10):679-83. PubMed ID: 22027241
[TBL] [Abstract][Full Text] [Related]
65. [Endovascular treatment of cerebral vasospasm due to aneurysmal subarachnoid hemorrhage].
Alcázar PP; González A; Romance A
Med Intensiva; 2008 Nov; 32(8):391-7. PubMed ID: 19055932
[TBL] [Abstract][Full Text] [Related]
66. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage.
Stippler M; Crago E; Levy EI; Kerr ME; Yonas H; Horowitz MB; Kassam A
J Neurosurg; 2006 Nov; 105(5):723-9. PubMed ID: 17121134
[TBL] [Abstract][Full Text] [Related]
67. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions.
Tejada JG; Taylor RA; Ugurel MS; Hayakawa M; Lee SK; Chaloupka JC
AJNR Am J Neuroradiol; 2007 May; 28(5):844-8. PubMed ID: 17494654
[TBL] [Abstract][Full Text] [Related]
68. Intra-Arterial Papaverine-Hydrochloride and Transluminal Balloon Angioplasty for Neurointerventional Management of Delayed-Onset Post-Aneurysmal Subarachnoid Hemorrhage Vasospasm.
Hosmann A; Rauscher S; Wang WT; Dodier P; Bavinzski G; Knosp E; Gruber A
World Neurosurg; 2018 Nov; 119():e301-e312. PubMed ID: 30053563
[TBL] [Abstract][Full Text] [Related]
69. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study.
Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M
In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526
[TBL] [Abstract][Full Text] [Related]
70. Intra-arterial injection of verapamil in treatment of cerebral vasospasm in a patient with acute subarachnoid hemorrhage from an aneurysm: case report.
Mikeladze KG; Éliava ShSh; Shekhtman OD; Lubnin AIu; Tabasaranskiĭ TF; Iakovlev SB
Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(4):57-60; discussion 60. PubMed ID: 24364247
[TBL] [Abstract][Full Text] [Related]
71. Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
Carlson AP; Hänggi D; Wong GK; Etminan N; Mayer SA; Aldrich F; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Bleck T; Grubb R; Miller M; Suarez JI; Proskin HM; Macdonald RL;
Stroke; 2020 Apr; 51(4):1142-1149. PubMed ID: 32138631
[TBL] [Abstract][Full Text] [Related]
72. Temporal evolution of vasospasm and clinical outcome after intra-arterial vasodilator therapy in patients with aneurysmal subarachnoid hemorrhage.
Daftari Besheli L; Tan CO; Bell DL; Hirsch JA; Gupta R
PLoS One; 2017; 12(3):e0174676. PubMed ID: 28339483
[TBL] [Abstract][Full Text] [Related]
73. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Keuskamp J; Murali R; Chao KH
J Neurosurg; 2008 Mar; 108(3):458-63. PubMed ID: 18312091
[TBL] [Abstract][Full Text] [Related]
74. Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
Vázquez-Medina A; Turnbull MT; James CL; Cowart JB; Lesser E; Carter RE; Ross OA; Miller DA; Meschia JF; De Jesús Espinosa A; Weinshilboum R; Freeman WD
Pharmacogenomics J; 2024 Jun; 24(4):19. PubMed ID: 38890281
[TBL] [Abstract][Full Text] [Related]
75. Real-Time, In Vivo Monitoring, and Quantitative Assessment of Intra-Arterial Vasospasm Therapy.
Gölitz P; Kaschka I; Lang S; Roessler K; Knossalla F; Doerfler A
Neurocrit Care; 2016 Aug; 25(1):40-6. PubMed ID: 26690939
[TBL] [Abstract][Full Text] [Related]
76. The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage.
Isse FA; Abdallah YEH; Mahmoud SH
J Pharm Pharm Sci; 2020; 23(1):100-108. PubMed ID: 32348716
[TBL] [Abstract][Full Text] [Related]
77. Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article.
Albanese E; Russo A; Quiroga M; Willis RN; Mericle RA; Ulm AJ
J Neurosurg; 2010 Oct; 113(4):913-22. PubMed ID: 19877802
[TBL] [Abstract][Full Text] [Related]
78. Nimodipine: test your drug IQ.
Devlin MM
Nursing; 2008 Jul; 38(7):56cc1-2. PubMed ID: 18580671
[TBL] [Abstract][Full Text] [Related]
79. Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Mori K; Yamamoto T; Nakao Y; Osada H; Hara Y; Oyama K; Esaki T
Neurol Med Chir (Tokyo); 2009 Apr; 49(4):139-44; discussion 144-5. PubMed ID: 19398856
[TBL] [Abstract][Full Text] [Related]
80. Influence of nimodipine combined with ulinastatin on neurological function and inflammatory reaction in patients with cerebral vasospasm after subarachnoid hemorrhage.
Chen M; Zhang Q; Liu H; Zou W; Wei X
Clin Neurol Neurosurg; 2021 Nov; 210():106981. PubMed ID: 34700272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
